taxonomy (1)
protein (1)
source (6)
structure (43)
composition (74)
disease (6)
reference (16)
site (7)
peptide (24)
- Homo sapiens (Human)
Taxonomy
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Cerebrospinal Fluid (UBERON_0001359)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Urine (UBERON_0001088)
Source
- N-Linked / Complex / Structure 2011
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 10712
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 3041
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / Structure 3507
- N-Linked / Complex / Structure 32
- N-Linked / Complex / Structure 644
- N-Linked / Complex / Structure 1523
- N-Linked / Complex / Structure 10692
- N-Linked / Complex / NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 10728
- N-Linked / Complex / Structure 9425
- N-Linked / Complex / Structure 9470
- N-Linked / Complex / Structure 1519
- N-Linked / Complex / Structure 10694
- N-Linked / Complex / Structure 10721
- N-Linked / Complex / Structure 10725
- N-Linked / Complex / Structure 10785
- N-Linked / Complex / Structure 9462
- N-Linked / Complex / Structure 10693
- N-Linked / Complex / Structure 10752
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)]Man(a1-?)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-?)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 9441
- N-Linked / Complex / Structure 10791
- N-Linked / Complex / Structure 10805
- N-Linked / Complex / Structure 10750
- N-Linked / Complex / Structure 10759
- N-Linked / Complex / Structure 10803
- N-Linked / Complex / Structure 10792
- N-Linked / Complex / Structure 10774
- N-Linked / Complex / Structure 10689
- N-Linked / Complex / Structure 10751
- N-Linked / Complex / Structure 10701
- N-Linked / Complex / Structure 10770
- N-Linked / Complex / Structure 10719
- N-Linked / Hybrid / Structure 9488
- N-Linked / Hybrid / Structure 2063
- N-Linked / Hybrid / Structure 9506
- N-Linked / Hybrid / Structure 9475
Reported structure
- HexNAc:1 (avg mass : 221.2103 )
- Hex:3 HexNAc:2 (avg mass : 910.8325 )
- Hex:3 HexNAc:6 dHex:2 NeuAc:1 (avg mass : 2307.1564 )
- Hex:3 HexNAc:7 (avg mass : 1926.8075 )
- Hex:3 HexNAc:9 dHex:1 (avg mass : 2479.3405 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2062.9088 )
- Hex:4 HexNAc:5 NeuAc:1 NeuGc:1 (avg mass : 2281.0751 )
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2266.1038 )
- Hex:4 HexNAc:5 dHex:3 (avg mass : 2120.9889 )
- Hex:4 HexNAc:6 dHex:1 (avg mass : 2031.8979 )
- Hex:4 HexNAc:6 dHex:2 (avg mass : 2178.0409 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 NeuAc:3 (avg mass : 2515.281 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 NeuGc:1 (avg mass : 2386.1655 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 (avg mass : 1933.7933 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 (avg mass : 2371.1942 )
- Hex:5 HexNAc:5 NeuAc:2 (avg mass : 2427.2181 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2573.3611 )
- Hex:5 HexNAc:5 dHex:2 (avg mass : 2136.9883 )
- Hex:5 HexNAc:6 dHex:1 (avg mass : 2194.0403 )
- Hex:5 HexNAc:6 dHex:3 (avg mass : 2486.3263 )
- Hex:5 HexNAc:8 (avg mass : 2454.2873 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 NeuAc:2 (avg mass : 2386.1655 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2387.1936 )
- Hex:6 HexNAc:4 dHex:3 (avg mass : 2242.0787 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 NeuAc:4 (avg mass : 3171.8763 )
- Hex:6 HexNAc:5 NeuAc:5 (avg mass : 3463.1342 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:4 (avg mass : 3318.0193 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2590.3886 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:2 (avg mass : 2881.6465 )
- Hex:6 HexNAc:5 dHex:2 NeuAc:3 (avg mass : 3172.9044 )
- Hex:6 HexNAc:6 (avg mass : 2210.0397 )
- Hex:6 HexNAc:6 NeuAc:2 (avg mass : 2792.5555 )
- Hex:6 HexNAc:6 dHex:1 (avg mass : 2356.1827 )
- Hex:6 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 2938.6985 )
- Hex:6 HexNAc:7 (avg mass : 2413.2347 )
- Hex:7 HexNAc:4 NeuAc:1 (avg mass : 2257.05 )
- Hex:7 HexNAc:4 dHex:1 (avg mass : 2111.9351 )
- Hex:7 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2897.6459 )
- Hex:7 HexNAc:6 NeuAc:2 (avg mass : 2954.6979 )
- Hex:7 HexNAc:6 NeuAc:3 (avg mass : 3245.9558 )
- Hex:7 HexNAc:6 NeuAc:4 (avg mass : 3537.2137 )
- Hex:7 HexNAc:6 NeuAc:5 (avg mass : 3828.4716 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:3 (avg mass : 3392.0988 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:4 (avg mass : 3683.3567 )
- Hex:7 HexNAc:6 dHex:2 NeuAc:4 (avg mass : 3829.4997 )
- Hex:7 HexNAc:6 dHex:3 NeuAc:1 (avg mass : 3101.869 )
- Hex:8 HexNAc:3 dHex:3 NeuAc:1 (avg mass : 2654.4264 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Cancer, breast (DOID:1612)
- Carcinoma, Hepatocellular (DOID:684)
- Control/Healthy
- Esophageal cancer (DOID:5041)
- Familial hepatic adenoma (DOID:111366)
- Prostate cancer (DOID:10283)
Disease
- Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis (2021 - Luisa Sturiale, Marie-Cécile Nassogne, Angelo Palmigiano, Angela Messina, Immacolata Speciale, Rosangela Artuso, Gaetano Bertino, Nicole Revencu, Xavier Stephénne, Cristina De Castro, Gert Matthijs, Rita Barone, Jaak Jaeken, Domenico Garozzo) / Status : Reviewed
- Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis (2021 - Rebeca Kawahara, Anastasia Chernykh, Kathirvel Alagesan, Marshall Bern, Weiqian Cao, Robert J. Chalkley, Kai Cheng, Matthew S. Choo, Nathan Edwards, Radoslav Goldman, Marcus Hoffmann, Yingwei Hu, Yifan Huang, Jin Young Kim, Doron Kletter, Benoit Liquet, Mingqi Liu, Yehia Mechref, Bo Meng, Sriram Neelamegham, Terry Nguyen-Khuong, Jonas Nilsson, Adam Pap, Gun Wook Park, Benjamin L. Parker, Cassandra L. Pegg, Josef M. Penninger, Toan K. Phung, Markus Pioch, Erdmann Rapp, Enes Sakalli, Miloslav Sanda, Benjamin L. Schulz, Nichollas E. Scott, Georgy Sofronov, Johannes Stadlmann, Sergey Y. Vakhrushev, Christina M. Woo, Hung-Yi Wu, Pengyuan Yang, Wantao Ying, Hui Zhang, Yong Zhang, Jingfu Zhao, Joseph Zaia, Stuart M. Haslam, Giuseppe Palmisano, Jong Shin Yoo, Göran Larson, Kai-Hooi Khoo, Katalin F. Medzihradszky, Daniel Kolarich, Nicolle H. Packer, Morten Thaysen-Andersen) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Glycomic analysis of high density lipoprotein shows a highly sialylated particle (2014 - Huang J1, Lee H, Zivkovic AM, Smilowitz JT, Rivera N, German JB, Lebrilla CB) / Status : Reviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Computational framework for identification of intact glycopeptides in complex samples (2014 - Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H.) / Status : Reviewed
- Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD (2012 - Halim A, Nilsson J, Rüetschi U, Hesse C, Larson G) / Status : Reviewed
- Enrichment of glycopeptides for glycan structure and attachment site identification (2009 - Nilsson J, Rüetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G.) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma. (1993 - Saitoh A, Aoyagi Y, Asakura H) / Status : Reviewed
- Studies on the oligosaccharide chains of human alpha 1-protease inhibitor. II. Structure of oligosaccharides. (1980 - Mega T, Lujan E, Yoshida A) / Status : Reviewed
Reference
- Alpha-1-antitrypsin / Homo sapiens
Reported glycosite
- QLAHQSNSTNIFFSPVSIATAFAMLSLGTK (30aa)
- QLAHQSNSTNIFFSPVSIATAF (22aa)
- QLAHQSNSTNIFFSPV (16aa)
- QLAHQSNSTNIF (12aa)
- QLAHQSNSTNIFF (13aa)
- ADTHDEILEGLNFNLTEIPEAQIHEGFQEL (30aa)
- ADTHDEILEGLNFNLTEIPEAQ (22aa)
- ADTHDEILEGLNFNLTEIPEAQIH (24aa)
- ADTHDEILEGLNFNLTEIPEAQIHEGF (27aa)
- ADTHDEILEGLNFNLTEIPEAQIHE (25aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- ADTHDEILEGLNFNLTEIPEAQIHEG (26aa)
- ADTHDEILEGLNFNLT (16aa)
- ADTHDEILEGLNFNLTEIPEAQIHEGFQELLR (32aa)
- KYLGNATAIFFLPDEGKL (18aa)
- NATAIFFLPDEGK (13aa)
- YIGNATAIFFIPDEGKIQHIENEITHDIITK (31aa)
- YLGNATAI (8aa)
- YIGNATAIFFIPDEGK (16aa)
- LGNATAIFFLPDEGK (15aa)
- KYLGNATAIFFLPDEGK (17aa)
- YLGNATAIF (9aa)
- YLGNATAIFFLPDEGK (16aa)
- VVNPTQK (7aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 1479.3649)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1641.5073)
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Enrichment of glycopeptides for glycan structure and attachment site identification (2009 - Nilsson J, Rüetschi U, Halim A, Hesse C, Carlsohn E, Brinkmalm G, Larson G.) / Status : Reviewed
- Alpha-1-antitrypsin / Homo sapiens
- KYLGNATAIFFLPDEGKL (18aa)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1641.5073)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1641.5073)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Blood Serum (UBERON_0001977)
- Carcinoma, Hepatocellular (DOID:684)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1787.6503)
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1932.7652)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1932.7652)
- Milk (UBERON_0001913)
- Alpha-1-antitrypsin / Homo sapiens
- KYLGNATAIFFLPDEGKL (18aa)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 1933.7933)
- Milk (UBERON_0001913)
- Alpha-1-antitrypsin / Homo sapiens
- KYLGNATAIFFLPDEGKL (18aa)
-
- N-Linked / Complex
(avg mass : 2006.8447)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Milk (UBERON_0001913)
- Alpha-1-antitrypsin / Homo sapiens
- KYLGNATAIFFLPDEGKL (18aa)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2078.9082)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2224.0231)
- Esophageal cancer (DOID:5041)
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Computational framework for identification of intact glycopeptides in complex samples (2014 - Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H.) / Status : Reviewed
- Alpha-1-antitrypsin / Homo sapiens
- KYLGNATAIFFLPDEGKL (18aa)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2225.0512)
- Milk (UBERON_0001913)
- Alpha-1-antitrypsin / Homo sapiens
- KYLGNATAIFFLPDEGKL (18aa)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2298.1026)
- Milk (UBERON_0001913)
- Alpha-1-antitrypsin / Homo sapiens
- KYLGNATAIFFLPDEGKL (18aa)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2370.1661)
- Milk (UBERON_0001913)
- Alpha-1-antitrypsin / Homo sapiens
- KYLGNATAIFFLPDEGKL (18aa)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2370.1661)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2515.281)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2573.3611)
- Blood Serum (UBERON_0001977)
- Control/Healthy
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2573.3611)
- Blood Serum (UBERON_0001977)
- Control/Healthy
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Milk (UBERON_0001913)
- Alpha-1-antitrypsin / Homo sapiens
- KYLGNATAIFFLPDEGKL (18aa)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2589.3605)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2735.5035)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2880.6184)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2880.6184)
- Milk (UBERON_0001913)
- Alpha-1-antitrypsin / Homo sapiens
- KYLGNATAIFFLPDEGKL (18aa)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 2880.6184)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3026.7614)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3171.8763)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3172.9044)
- Blood Serum (UBERON_0001977)
- Control/Healthy
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3245.9558)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3318.0193)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3392.0988)
- Blood Serum (UBERON_0001977)
- Control/Healthy
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3463.1342)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3537.2137)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3683.3567)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3828.4716)
- Blood Serum (UBERON_0001977)
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3829.4997)
- Blood Serum (UBERON_0001977)
- Control/Healthy
-
Alpha-1-antitrypsin / Homo sapiens
- Undefined site
-
- N-Linked / Hybrid
(avg mass : 1567.4278)
- Milk (UBERON_0001913)
- Alpha-1-antitrypsin / Homo sapiens
- KYLGNATAIFFLPDEGKL (18aa)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Hybrid
(avg mass : 1729.5702)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Hybrid
(avg mass : 2094.9076)
- Milk (UBERON_0001913)
- Alpha-1-antitrypsin / Homo sapiens
- KYLGNATAIFFLPDEGKL (18aa)
- Alpha-1-antitrypsin / Homo sapiens
-
- N-Linked / Hybrid
(avg mass : 2241.0506)
- Milk (UBERON_0001913)
- Alpha-1-antitrypsin / Homo sapiens
- KYLGNATAIFFLPDEGKL (18aa)
- Alpha-1-antitrypsin / Homo sapiens
-
- Hex:3 HexNAc:2 / N-Linked
(avg mass : 910.8325)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked
(avg mass : 1567.4278)
- N-Linked / Hybrid / Structure 9488
- Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis (2021 - Rebeca Kawahara, Anastasia Chernykh, Kathirvel Alagesan, Marshall Bern, Weiqian Cao, Robert J. Chalkley, Kai Cheng, Matthew S. Choo, Nathan Edwards, Radoslav Goldman, Marcus Hoffmann, Yingwei Hu, Yifan Huang, Jin Young Kim, Doron Kletter, Benoit Liquet, Mingqi Liu, Yehia Mechref, Bo Meng, Sriram Neelamegham, Terry Nguyen-Khuong, Jonas Nilsson, Adam Pap, Gun Wook Park, Benjamin L. Parker, Cassandra L. Pegg, Josef M. Penninger, Toan K. Phung, Markus Pioch, Erdmann Rapp, Enes Sakalli, Miloslav Sanda, Benjamin L. Schulz, Nichollas E. Scott, Georgy Sofronov, Johannes Stadlmann, Sergey Y. Vakhrushev, Christina M. Woo, Hung-Yi Wu, Pengyuan Yang, Wantao Ying, Hui Zhang, Yong Zhang, Jingfu Zhao, Joseph Zaia, Stuart M. Haslam, Giuseppe Palmisano, Jong Shin Yoo, Göran Larson, Kai-Hooi Khoo, Katalin F. Medzihradszky, Daniel Kolarich, Nicolle H. Packer, Morten Thaysen-Andersen) / Status : Reviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:4 / N-Linked
(avg mass : 1641.5073)
- N-Linked / Complex / Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 10712
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Human urinary glycoproteomics; attachment site specific analysis of N- and O-linked glycosylations by CID and ECD (2012 - Halim A, Nilsson J, Rüetschi U, Hesse C, Larson G) / Status : Reviewed
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 1770.6228)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1787.6503)
- Blood Plasma (UBERON_0001969)
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 3041
- Alpha-1-antitrypsin / Homo sapiens
-
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1916.7658)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:3 HexNAc:7 / N-Linked
(avg mass : 1926.8075)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 1932.7652)
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ NeuAc"
- N-Linked / Complex / Structure 3507
- Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis (2021 - Rebeca Kawahara, Anastasia Chernykh, Kathirvel Alagesan, Marshall Bern, Weiqian Cao, Robert J. Chalkley, Kai Cheng, Matthew S. Choo, Nathan Edwards, Radoslav Goldman, Marcus Hoffmann, Yingwei Hu, Yifan Huang, Jin Young Kim, Doron Kletter, Benoit Liquet, Mingqi Liu, Yehia Mechref, Bo Meng, Sriram Neelamegham, Terry Nguyen-Khuong, Jonas Nilsson, Adam Pap, Gun Wook Park, Benjamin L. Parker, Cassandra L. Pegg, Josef M. Penninger, Toan K. Phung, Markus Pioch, Erdmann Rapp, Enes Sakalli, Miloslav Sanda, Benjamin L. Schulz, Nichollas E. Scott, Georgy Sofronov, Johannes Stadlmann, Sergey Y. Vakhrushev, Christina M. Woo, Hung-Yi Wu, Pengyuan Yang, Wantao Ying, Hui Zhang, Yong Zhang, Jingfu Zhao, Joseph Zaia, Stuart M. Haslam, Giuseppe Palmisano, Jong Shin Yoo, Göran Larson, Kai-Hooi Khoo, Katalin F. Medzihradszky, Daniel Kolarich, Nicolle H. Packer, Morten Thaysen-Andersen) / Status : Reviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- QLAHQSNSTNIFFSPVSIATAFAMLSLGTK (30aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAI (8aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1949.7927)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:6 dHex:1 / N-Linked
(avg mass : 2031.8979)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2062.9088)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2078.9082)
- N-Linked / Complex / Structure 1523
- N-Linked / Complex / Structure 10692
- Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis (2021 - Rebeca Kawahara, Anastasia Chernykh, Kathirvel Alagesan, Marshall Bern, Weiqian Cao, Robert J. Chalkley, Kai Cheng, Matthew S. Choo, Nathan Edwards, Radoslav Goldman, Marcus Hoffmann, Yingwei Hu, Yifan Huang, Jin Young Kim, Doron Kletter, Benoit Liquet, Mingqi Liu, Yehia Mechref, Bo Meng, Sriram Neelamegham, Terry Nguyen-Khuong, Jonas Nilsson, Adam Pap, Gun Wook Park, Benjamin L. Parker, Cassandra L. Pegg, Josef M. Penninger, Toan K. Phung, Markus Pioch, Erdmann Rapp, Enes Sakalli, Miloslav Sanda, Benjamin L. Schulz, Nichollas E. Scott, Georgy Sofronov, Johannes Stadlmann, Sergey Y. Vakhrushev, Christina M. Woo, Hung-Yi Wu, Pengyuan Yang, Wantao Ying, Hui Zhang, Yong Zhang, Jingfu Zhao, Joseph Zaia, Stuart M. Haslam, Giuseppe Palmisano, Jong Shin Yoo, Göran Larson, Kai-Hooi Khoo, Katalin F. Medzihradszky, Daniel Kolarich, Nicolle H. Packer, Morten Thaysen-Andersen) / Status : Reviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- QLAHQSNSTNIFFSPVSIATAFAMLSLGTK (30aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
- VVNPTQK (7aa)
-
- Hex:5 HexNAc:4 dHex:3 / N-Linked
(avg mass : 2079.9363)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- NATAIFFLPDEGK (13aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 2094.9076)
- N-Linked / Hybrid / Structure 9506
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:7 HexNAc:4 dHex:1 / N-Linked
(avg mass : 2111.9351)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:5 dHex:3 / N-Linked
(avg mass : 2120.9889)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- NATAIFFLPDEGK (13aa)
-
- Hex:5 HexNAc:5 dHex:2 / N-Linked
(avg mass : 2136.9883)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:5 dHex:1 / N-Linked
(avg mass : 2152.9877)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:6 dHex:2 / N-Linked
(avg mass : 2178.0409)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:6 dHex:1 / N-Linked
(avg mass : 2194.0403)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAI (8aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:6 / N-Linked
(avg mass : 2210.0397)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked
(avg mass : 2224.0231)
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- N-Linked / Complex / NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 10728
- Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis (2021 - Rebeca Kawahara, Anastasia Chernykh, Kathirvel Alagesan, Marshall Bern, Weiqian Cao, Robert J. Chalkley, Kai Cheng, Matthew S. Choo, Nathan Edwards, Radoslav Goldman, Marcus Hoffmann, Yingwei Hu, Yifan Huang, Jin Young Kim, Doron Kletter, Benoit Liquet, Mingqi Liu, Yehia Mechref, Bo Meng, Sriram Neelamegham, Terry Nguyen-Khuong, Jonas Nilsson, Adam Pap, Gun Wook Park, Benjamin L. Parker, Cassandra L. Pegg, Josef M. Penninger, Toan K. Phung, Markus Pioch, Erdmann Rapp, Enes Sakalli, Miloslav Sanda, Benjamin L. Schulz, Nichollas E. Scott, Georgy Sofronov, Johannes Stadlmann, Sergey Y. Vakhrushev, Christina M. Woo, Hung-Yi Wu, Pengyuan Yang, Wantao Ying, Hui Zhang, Yong Zhang, Jingfu Zhao, Joseph Zaia, Stuart M. Haslam, Giuseppe Palmisano, Jong Shin Yoo, Göran Larson, Kai-Hooi Khoo, Katalin F. Medzihradszky, Daniel Kolarich, Nicolle H. Packer, Morten Thaysen-Andersen) / Status : Reviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Comparison of sialylated N-glycopeptide levels in serum of pancreatic cancer patients, acute pancreatitis patients, and healthy controls (2014 - Kontro H, Joenväärä S, Haglund C, Renkonen R) / Status : Reviewed
- Glycomic analysis of high density lipoprotein shows a highly sialylated particle (2014 - Huang J1, Lee H, Zivkovic AM, Smilowitz JT, Rivera N, German JB, Lebrilla CB) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Alpha-1-antitrypsin / Homo sapiens
- QLAHQSNSTNIFFSPVSIATAFAMLSLGTK (30aa)
- QLAHQSNSTNIFFSPVSIATAF (22aa)
- QLAHQSNSTNIFFSPV (16aa)
- QLAHQSNSTNIF (12aa)
- QLAHQSNSTNIFF (13aa)
- ADTHDEILEGLNFNLTEIPEAQIHEGFQEL (30aa)
- ADTHDEILEGLNFNLTEIPEAQ (22aa)
- ADTHDEILEGLNFNLTEIPEAQIH (24aa)
- ADTHDEILEGLNFNLTEIPEAQIHEGF (27aa)
- ADTHDEILEGLNFNLTEIPEAQIHE (25aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- ADTHDEILEGLNFNLTEIPEAQIHEG (26aa)
- ADTHDEILEGLNFNLT (16aa)
- NATAIFFLPDEGK (13aa)
- YIGNATAIFFIPDEGKIQHIENEITHDIITK (31aa)
- YLGNATAI (8aa)
- YIGNATAIFFIPDEGK (16aa)
- LGNATAIFFLPDEGK (15aa)
- KYLGNATAIFFLPDEGK (17aa)
- YLGNATAIF (9aa)
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2225.0512)
- N-Linked / Complex / Structure 9425
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2241.0506)
- N-Linked / Hybrid / Structure 9475
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAI (8aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:4 dHex:3 / N-Linked
(avg mass : 2242.0787)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:7 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 2257.05)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2266.1038)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:4 HexNAc:5 NeuAc:1 NeuGc:1 / N-Linked
(avg mass : 2281.0751)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2282.1032)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2298.1026)
- N-Linked / Complex / Structure 9470
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Alpha-1-antitrypsin / Homo sapiens
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- VVNPTQK (7aa)
-
- Hex:3 HexNAc:6 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2307.1564)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:6 HexNAc:6 dHex:1 / N-Linked
(avg mass : 2356.1827)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:12 HexNAc:2 / N-Linked
(avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Alpha-1-antitrypsin / Homo sapiens
- QLAHQSNSTNIFFSPVSIATAFAMLSLGTK (30aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAI (8aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2370.1661)
- N-Linked / Complex / Structure 1519
- N-Linked / Complex / Structure 10694
- Community evaluation of glycoproteomics informatics solutions reveals high-performance search strategies for serum glycopeptide analysis (2021 - Rebeca Kawahara, Anastasia Chernykh, Kathirvel Alagesan, Marshall Bern, Weiqian Cao, Robert J. Chalkley, Kai Cheng, Matthew S. Choo, Nathan Edwards, Radoslav Goldman, Marcus Hoffmann, Yingwei Hu, Yifan Huang, Jin Young Kim, Doron Kletter, Benoit Liquet, Mingqi Liu, Yehia Mechref, Bo Meng, Sriram Neelamegham, Terry Nguyen-Khuong, Jonas Nilsson, Adam Pap, Gun Wook Park, Benjamin L. Parker, Cassandra L. Pegg, Josef M. Penninger, Toan K. Phung, Markus Pioch, Erdmann Rapp, Enes Sakalli, Miloslav Sanda, Benjamin L. Schulz, Nichollas E. Scott, Georgy Sofronov, Johannes Stadlmann, Sergey Y. Vakhrushev, Christina M. Woo, Hung-Yi Wu, Pengyuan Yang, Wantao Ying, Hui Zhang, Yong Zhang, Jingfu Zhao, Joseph Zaia, Stuart M. Haslam, Giuseppe Palmisano, Jong Shin Yoo, Göran Larson, Kai-Hooi Khoo, Katalin F. Medzihradszky, Daniel Kolarich, Nicolle H. Packer, Morten Thaysen-Andersen) / Status : Reviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Simultaneous glycosylation analysis of human serum glycoproteins by high-performance liquid chromatography/tandem mass spectrometry (2008 - Harazono A, Kawasaki N, Itoh S, Hashii N, Matsuishi-Nakajima Y, Kawanishi T, Yamaguchi T) / Status : Reviewed
- Alpha-1-antitrypsin / Homo sapiens
- QLAHQSNSTNIFFSPVSIATAFAMLSLGTK (30aa)
- ADTHDEIIEGINFNITEIPEAQIHEGFQEIIR (32aa)
- YLGNATAIFFLPDEGK (16aa)
- YIGNATAIFFIPDEGK (16aa)
-
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 / N-Linked
(avg mass : 2371.1942)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 NeuGc:1 / N-Linked
(avg mass : 2386.1655)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:6 HexNAc:4 NeuAc:2 / N-Linked
(avg mass : 2386.1655)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
- Alpha-1-antitrypsin / Homo sapiens
- YLGNATAIFFLPDEGK (16aa)
-
- Hex:6 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2387.1936)
- Blood Serum (UBERON_0001977)
- Prostate cancer (DOID:10283)
-
Alpha-1-antitrypsin / Homo sapiens
Source
Suggested structure
Disease
Reported glycosite
- Hex:6 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2387.1936)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:4 NeuAc:2 / N-Linked
(avg mass : 2386.1655)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 NeuGc:1 / N-Linked
(avg mass : 2386.1655)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:3 NeuAc:1 / N-Linked
(avg mass : 2371.1942)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2370.1661)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:12 HexNAc:2 / N-Linked
(avg mass : 2370.1141)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:6 dHex:1 / N-Linked
(avg mass : 2356.1827)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:6 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2307.1564)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2298.1026)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2282.1032)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 NeuAc:1 NeuGc:1 / N-Linked
(avg mass : 2281.0751)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2266.1038)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 2257.05)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:4 dHex:3 / N-Linked
(avg mass : 2242.0787)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2241.0506)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2225.0512)
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked
(avg mass : 2224.0231)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:6 / N-Linked
(avg mass : 2210.0397)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:6 dHex:1 / N-Linked
(avg mass : 2194.0403)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:6 dHex:2 / N-Linked
(avg mass : 2178.0409)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:1 / N-Linked
(avg mass : 2152.9877)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:5 dHex:2 / N-Linked
(avg mass : 2136.9883)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:3 / N-Linked
(avg mass : 2120.9889)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:4 dHex:1 / N-Linked
(avg mass : 2111.9351)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 2094.9076)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:3 / N-Linked
(avg mass : 2079.9363)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2078.9082)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2062.9088)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:6 dHex:1 / N-Linked
(avg mass : 2031.8979)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1949.7927)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 1932.7652)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:7 / N-Linked
(avg mass : 1926.8075)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1916.7658)
Source
Suggested structure
Reported glycosite
- Hex:5 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1787.6503)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 1770.6228)
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 / N-Linked
(avg mass : 1641.5073)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked
(avg mass : 1567.4278)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:2 / N-Linked
(avg mass : 910.8325)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Hybrid
(avg mass : 2241.0506)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Hybrid
(avg mass : 2094.9076)
Source
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Hybrid
(avg mass : 1729.5702)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Hybrid
(avg mass : 1567.4278)
Source
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3829.4997)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3828.4716)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3683.3567)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3537.2137)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3463.1342)
Source
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3392.0988)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3318.0193)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3245.9558)
Source
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3172.9044)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3171.8763)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 3026.7614)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2880.6184)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2880.6184)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2880.6184)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2735.5035)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2589.3605)
Source
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2573.3611)
Source
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2573.3611)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2515.281)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2370.1661)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2370.1661)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2298.1026)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2225.0512)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2224.0231)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2224.0231)
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2224.0231)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 2078.9082)
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 2006.8447)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1933.7933)
Source
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1932.7652)
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Source
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1787.6503)
Source
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1641.5073)
Source
Disease
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1641.5073)
Reference
Reported glycosite
Mass spectrometry observed peptide
Suggested glycosite
- N-Linked / Complex
(avg mass : 1641.5073)
Reported glycosite
Suggested glycosite
- N-Linked / Complex
(avg mass : 1479.3649)